JAY GLADSTEIN: Open Payments
NPI 1154428613 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$125,046 in 235 payments from 23 companies in 2025. Trend: 2023 $116,446 · 2024 $143,424 · 2025 $125,046
Speaker / faculty: $89,085Consulting: $16,920Travel & lodging: $11,456Food & beverage: $7,585
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 84 | $73,283 |
| ViiV Healthcare Company | 100 | $50,423 |
| ABBVIE INC. | 11 | $312 |
| Corium, LLC | 4 | $128 |
| EMD Serono, Inc. | 3 | $116 |
| Bausch Health US, LLC | 4 | $80 |
| Antares Pharma, Inc. | 3 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $71 |
| Lilly USA, LLC | 3 | $68 |
Products named: CABENUVA, Biktarvy, Yeztugo, Descovy, DOVATO, APRETUDE, VRAYLAR, Azstarys.
Industry payments across CA — which companies pay providers there.
